Centre Hospitalier Princesse Grace Report issue

Academic/Hospital Phase 3 Phase 4

Organization Overview

First Clinical Trial
2014
NCT02287896
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Centre Hospitalier Princesse Grace | Centre Hospitalier Princesse Grace - Monaco | Centre Mémoire, Centre de Gérontologie Clinique RAINIER III, Princess Grace Hospital (Monaco) | Centre Mémoire, Centre de Gérontologie Clinique RAINIER III, Princess Grace Hospital, Monaco | Centre Mémoire, Centre de Gérontologie Clinique RAINIER III, Princess Grace Hospital, Monaco. | CH Princesse Grace de Monaco | Médecine Nucléaire, Princess Grace Hospital, Monaco.

Active Ingredients

Drugs in Phase 4 Trials (2)

midazolam (versed) (1 trial)

sodium oxybate (xyrem) (1 trial)

Drugs in Phase 3 Trials (1)

roledumab (1 trial)

Drugs in Other Trials (1)

apolipoprotein (1 trial)

Indications

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 4